Last reviewed · How we verify
Small intestinal release peppermint oil — Competitive Intelligence Brief
phase 3
Gastrointestinal motility agent
Gastrointestinal
Small molecule
Live · refreshed every 30 min
Target snapshot
Small intestinal release peppermint oil (Small intestinal release peppermint oil) — Maastricht University Medical Center. Peppermint oil works by relaxing the muscles in the small intestine, reducing spasms and cramping.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Small intestinal release peppermint oil TARGET | Small intestinal release peppermint oil | Maastricht University Medical Center | phase 3 | Gastrointestinal motility agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Gastrointestinal motility agent class)
- Maastricht University Medical Center · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Small intestinal release peppermint oil CI watch — RSS
- Small intestinal release peppermint oil CI watch — Atom
- Small intestinal release peppermint oil CI watch — JSON
- Small intestinal release peppermint oil alone — RSS
- Whole Gastrointestinal motility agent class — RSS
Cite this brief
Drug Landscape (2026). Small intestinal release peppermint oil — Competitive Intelligence Brief. https://druglandscape.com/ci/small-intestinal-release-peppermint-oil. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab